ADMA Biologics Inc (ADMA)

ADMA Biologics Inc (ADMA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.4B; returns 1 day -2.5%, 1 week +0.0%, 1 year -30.0%.

ADMA Biologics Inc. is a vertically integrated commercial biopharmaceutical company primarily focused on developing, manufacturing, and commercializing specialty plasma-derived biologics for the treatment and prevention of infectious diseases and the management of immune-compromised patient populations.

Groups ADMA belongs to

• Shrinking Share Count
• Biopharmaceutical
• Biologics
• Healthcare
• Commercial Stage
• Infectious Diseases
• Plasma Collection
• Vertical Integration
• Pharmaceuticals
• Specialty Chemicals
• Life Sciences
• Manufacturing

ADMA financial model: income statement, cash flow and balance sheet